Podcast - Cybersecurity Roundup: Analyzing New and Proposed Rules for Contractors
Cybersecurity Insights: Updates on CMMC Implementation and CUI Identification
Podcast - Third-Party Assessments and NIST SP 800-171
Third-Party Assessments and NIST SP 800-171
[Podcast] AI Risk Management: A Discussion with NIST’s Elham Tabassi on the NIST AI Risk Management Framework
Compliance into the Weeds - ChatGPT for the Compliance Professional
Nota Bene Episode 150: Building an AI Risk Management Framework with Siraj Husain
DoD Cyber: A Conversation with Melissa Vice, COO for DoD’s Vulnerability Disclosure Program
Cybersecurity and Data Privacy Year in Review: Major Breaches, Changes in the Law, and Upcoming Trends
The Government Contracts Cyber Café: Recent Developments Update
How to Respond to President Obama's Cybersecurity Executive Order
In our previous Mintz IRA Update, we covered the Biden administration’s proposal exploring the use of “march-in rights” granted under the Bayh-Doyle Act (the “Act”) to seize pharmaceutical patents if the administration...more
On February 6, 2024, the Federal Trade Commission (“FTC”) commented in support of what would be a historic expansion of government march-in rights under the Bayh-Dole Act in response to the release of the National Institute...more
The National Institute of Standards and Technology (NIST) released for public comment a “Draft Interagency Guidance Framework for Considering the Exercise of March In-Rights” (“March-In Framework”) on December 8, 2023...more
The Biden-Harris Administration recently announced various actions to lower healthcare and prescription drug costs. In one action, the National Institute of Standards and Technology (NIST) released in December 2023 a draft...more
The Situation: On December 8, 2023, the National Institute of Standards and Technology ("NIST") released a proposed framework for federal agencies regarding the exercise of the government's march-in rights for federally...more
Presented as part of its effort to lower what it views as excessive prices for prescription drugs, the Biden administration on December 7, 2023, announced the release of a proposed framework to expand the use of government...more
On December 7, the White House announced “New Actions to Lower Health Care and Prescription Drug Costs by Promoting Competition,” which included “a proposed framework for agencies on the exercise of march-in rights on...more